Kaspersky (www.Kaspersky.co.za) announces free availability of its core endpoint security products for medical organisations, in order to help them stay protected from cyberthreats during the pandemic. The full list of B2B products available for free for six months includes Kaspersky Endpoint Security Cloud Plus, Kaspersky Security for Microsoft Office 365, Kaspersky Endpoint Security for Business Advanced and Kaspersky Hybrid Cloud Security.
Continuity of operations and data protection is extremely critical for healthcare organisations. Especially in the current situation, when medical organisations are under extreme pressure and have to mobilise all their forces to help people in this very challenging time. For hospitals and medical institutions it is important to ensure the stability of medical equipment and that data is constantly available for medical personnel, while also protecting the privacy of their patients’ critical information.
To help medical organisations cope with the unprecedented pressure and help relieve cybersecurity risks that may arise during this period, Kaspersky has made its B2B solutions available for free. This includes endpoint and cloud infrastructure protection products, such as Kaspersky Endpoint Security for Business Advanced and Kaspersky Hybrid Cloud Security, SaaS endpoint protection – Kaspersky Endpoint Security Cloud Plus – and protection for Microsoft Office 365 – Kaspersky Security for Microsoft Office 365.
“In this critical situation, healthcare institutions are under immense pressure and carry huge responsibility while saving people’s lives and fighting against the infection. Doctors, nurses and all medical staff take on most of the load and therefore need any support possible. We feel that it is our duty to support the medical community,” said Evgeniya Naumova, Vice President of the Global Sales Network at Kaspersky. “In order to help these organisations focus on what matters most, we now offer healthcare institutions free licenses for key Kaspersky corporate products for a six month period.”
Along with this initiative, Kaspersky also suggests that medical institutions follow cybersecurity practices and implement the following measures as soon as possible:
For more detailed information about the offering and its availability please visit Kaspersky business blog (https://bitly.is/2UHawhY) and contact Kaspersky or its resellers.
Distributed by APO Group on behalf of Kaspersky.
For further information please contact:
Nicole Allman
INK&Co. (https://bit.ly/3dxSiYZ)
Cell: +27 83 251 2769
Email: nicole@inkandco.co.za
Facebook: https://bit.ly/2UpJXiB
Twitter: https://bit.ly/2WMT26H
Youtube: https://bit.ly/3amJ7Zv
Instagram: https://bit.ly/2wwsXhx
Kaspersky Blog: https://bit.ly/2Umetd7
About Kaspersky:
Kaspersky (www.Kaspersky.co.za) is a global cybersecurity company founded in 1997. Kaspersky’s deep threat intelligence and security expertise is constantly transforming into innovative security solutions and services to protect businesses, critical infrastructure, governments and consumers around the globe. The company’s comprehensive security portfolio includes leading endpoint protection and a number of specialized security solutions and services to fight sophisticated and evolving digital threats. Over 400 million users are protected by Kaspersky technologies and we help 270,000 corporate clients protect what matters most to them. Learn more at www.Kaspersky.co.za.
This website uses cookies.